{
    "clinical_study": {
        "@rank": "8321", 
        "arm_group": {
            "arm_group_label": "stem cells", 
            "arm_group_type": "Experimental", 
            "description": "autologous bone marrow mononuclear cell transplantation"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study was to study the effect of stem cell therapy on common symptoms in\n      patients with Traumatic Brain Injury"
        }, 
        "brief_title": "Stem Cell Therapy in Traumatic Brain Injury", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Traumatic Brain Injury", 
        "condition_browse": {
            "mesh_term": [
                "Brain Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosed cases of chronic traumatic brain injury\n\n          -  Age above 6 months\n\n        Exclusion Criteria:\n\n          -  presence of acute infections such as Human immunodeficiency virus/Hepatitis B -\n             Virus/Hepatitis C Virus\n\n          -  malignancies\n\n          -  bleeding tendencies\n\n          -  pneumonia\n\n          -  renal failure\n\n          -  severe liver dysfunction\n\n          -  severe anemia [Hemoglobin < 8]\n\n          -  any bone marrow disorder\n\n          -  space occupying lesion in brain\n\n          -  other acute medical conditions such as respiratory infection and pyrexia\n\n          -  pregnancy\n\n          -  lactation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "6 Months"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02028104", 
            "org_study_id": "NGBSI-06"
        }, 
        "intervention": {
            "arm_group_label": "stem cells", 
            "description": "bone marrow derived mononuclear cells are administered intrathecally in traumatic brain injury patients", 
            "intervention_name": "Autologous bone marrow mononuclear cell transplantation", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "January 3, 2014", 
        "location": {
            "contact": {
                "email": "alok276@gmail.com", 
                "last_name": "Alok K Sharma, M.S, M.Ch.", 
                "phone": "91-22-25281610"
            }, 
            "facility": {
                "address": {
                    "city": "Mumbai", 
                    "country": "India", 
                    "state": "Maharashtra", 
                    "zip": "400071"
                }, 
                "name": "Neurogen brain and spine institute"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "1", 
        "official_title": "Open Label Study of Autologous Bone Marrow Mononuclear Cells in Traumatic Brain Injury", 
        "other_outcome": {
            "measure": "SF-8 scale", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "overall_contact": {
            "email": "alok276@gmail.com", 
            "last_name": "Alok K Sharma, M.S, M.Ch", 
            "phone": "91-22-25281610"
        }, 
        "overall_official": {
            "affiliation": "Neurogen Brain and Spine Institute", 
            "last_name": "Alok K Sharma, M.S., M.Ch", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "India: Indian Council of Medical Research", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in clinical symptoms of traumatic brain injury", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "reference": [
            {
                "PMID": "23180314", 
                "citation": "Lee DH, Lee JY, Oh BM, Phi JH, Kim SK, Bang MS, Kim SU, Wang KC. Functional recovery after injury of motor cortex in rats: effects of rehabilitation and stem cell transplantation in a traumatic brain injury model of cortical resection. Childs Nerv Syst. 2013 Mar;29(3):403-11. doi: 10.1007/s00381-012-1969-4. Epub 2012 Nov 24."
            }, 
            {
                "PMID": "22891928", 
                "citation": "Tian C, Wang X, Wang X, Wang L, Wang X, Wu S, Wan Z. Autologous bone marrow mesenchymal stem cell therapy in the subacute stage of traumatic brain injury by lumbar puncture. Exp Clin Transplant. 2013 Apr;11(2):176-81. doi: 10.6002/ect.2012.0053. Epub 2012 Aug 11."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02028104"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Disability Rating scale", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "Neurogen Brain and Spine Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Neurogen Brain and Spine Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2010", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}